CAS 878143-33-0

Fórmula: C20H26N2O7S

InChI: InChI=1S/C19H20N2O3.CH4O3S.H2O/c22-18-10-21-12-5-11(18)6-13(21)8-14(7-12)24-19(23)16-9-20-17-4-2-1-3-15(16)17;1-5(2,3)4;/h1-4,9,11-14,20H,5-8,10H2;1H3,(H,2,3,4);1H2/t11?,12-,13+,14?;;

Chave InChI: QTFFGPOXNNGTGZ-RCSCTSIBSA-N

SMILES: CS(=O)(=O)O.C1[C@@H]2CC(C[C@H]3N2CC(=O)C1C3)OC(=O)C4=CNC5=CC=CC=C54.O

Dolasetron Mesylate Monohydrate

CAS: 878143-33-0

Fórmula: C₁₉H₂₀N₂O₃·CH₄O₃S·H₂O

Pureza: >98.0%(HPLC)

Cor e Forma: White to Almost white powder to crystal

Peso molecular: 438.50

Ref: 3B-D5481

Dolasetron Mesylate

CAS: 878143-33-0

Drugs with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoi

Fórmula: C₁₉H₂₀N₂O₃·CH₄O₃S·H₂O

Cor e Forma: White Off-White Crystalline Powder

Peso molecular: 324.14739

Ref: 45-1224959

Dalasetron Mesylate Hydrate

CAS: 878143-33-0

Dalasetron Mesylate Hydrate

Fórmula: C₁₉H₂₀N₂O₃CH₄O₃SH₂O

Pureza: 98%

Peso molecular: 438.49

Ref: 54-OR1026288

Dolasetron Mesylate hydrate

CAS: 878143-33-0

Dolasetron Mesylate hydrate blocks 5HT3 to prevent chemo and radiotherapy nausea.

Fórmula: C₂₀H₂₆N₂O₇S

Pureza: 99.86% - 99.99%

Cor e Forma: White Solid

Peso molecular: 438.49

Ref: TM-T2589

Dolasetron Mesylate Hydrate

CAS: 878143-33-0

Fórmula: C₁₉H₂₀N₂O₃CH₄O₃SH₂O

Peso molecular: 324.4 : 96.1 : 18.0

Ref: ST-EA-CP-D39005

Dalasetron (Mesylate hydrate)

CAS: 878143-33-0

Fórmula: C₂₀H₂₆N₂O₇S

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 438.4946

Ref: IN-DA00GU8A